Life Science Compliance Update

July

2016

July 2016: Life Science Compliance Update

Written by , Posted in July 2016 LSC Update, This Month in Compliance

The full text of the entire issue is now available to our subscribers. If you are a subscriber please log in now. You may also buy this issue by clicking on the button below.


   or   

July 2016 LSCU Cover

Issue Summary

The Government is actively bringing new cases, and the last 30 days are no exception. Therefore, we have devoted much of this month’s issue to covering the breaking cases. In addition, the July issue features articles on the origins of the Average Manufacturers Price from Chris Cobourn of Huron and the ability of CIA’s to create change by Melissa Hunt of Seattle Genetics.


Issue Articles

Arrow

History Repeating – Is Insys a Warner Chilcott Clone?
Kaitlin Fallon Wildoner, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

The Latest DOJ Setback – Jury Acquits Former Warner Chilcott Senior Executive
Matthew Hay, Special Contributing Editor, Life Science Compliance Update
Abstract

Arrow

Valeant Finally Able to Close One Troubled Door with Salix Settlement
Kaitlin Fallon Wildoner, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

Dentsply v. Bates: Taking a “Bite” Out of False Claim Act (FCA) Violations for Lack of Evidence
Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

Pfizer: Another Settlement Down
Kaitlin Fallon Wildoner, Esq., Staff Writer, Life Science Compliance Update
Abstract

Arrow

Unlikely Bedfellows: SEC Penalties When Industry Fails to Disclose FDA Recommendations for Clinical Trials
Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

What You Don’t Know About AMP Can Hurt You – Part 1
In the Beginning

Chris Cobourn, Managing Director, Huron Life Sciences
Abstract

Arrow

It’s A Brave New World or Is It? – CIAs and Their Ability to Create Change
Melissa Hunt, J.D., LL.M., Sr. Manager, Healthcare Compliance, Seattle Genetics
Abstract

Arrow

Give Thanks for Your Compliance Officers – Reviewing Public Citizen’s Study of Pharmaceutical Settlements
Kaitlin Fallon Wildoner, Esq., Staff Writer, Life Science Compliance Update
Abstract

Arrow

The Olympus Settlement – What It Can Tell Us About the Compliance Officer
Calisha Myers, Esq., Staff Writer – Life Science Compliance Update
Abstract

Menu Title